Bioventus Inc. Revenue 2019–2025
Bioventus Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bioventus Inc. revenue for the quarter ending March 28, 2026 was 132.1 M, a 6.63% increase year-over-year.
- Bioventus Inc. revenue for the twelve months ending March 28, 2026 was 542.3 M, a 0.34% increase year-over-year.
- Bioventus Inc. annual revenue for 2025 was 568.1 M, a 0.91% decrease from 2024.
- Bioventus Inc. annual revenue for 2024 was 573.3 M, a 11.89% increase from 2023.
- Bioventus Inc. annual revenue for 2023 was 512.3 M, a 0.04% increase from 2022.
- Bioventus Inc. annual revenue for 2022 was 512.1 M.
Bioventus Inc. (BVS) — Frequently Asked Questions
Bioventus Inc. (BVS) is a publicly traded US company. It has a market capitalization of $624M. In fiscal 2025 it reported revenue of $568M and net income of $23M. Explore BVS's stock price, financial statements, earnings history, margins and key ratios below.
What is Bioventus Inc.'s market cap?
Bioventus Inc. (BVS) has a market capitalization of $624M.
What is the BVS stock price?
BVS trades at $9.05 (-1.63% on the day).
How much revenue does Bioventus Inc. make?
Bioventus Inc. reported revenue of $568M in fiscal 2025.
Is BVS profitable?
In fiscal 2025, Bioventus Inc. reported net income of $23M.